We serve Chemical Name:CHLOROACETAMIDINE HYDROCHLORIDE CAS:10300-69-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:CHLOROACETAMIDINE HYDROCHLORIDE
CAS.NO:10300-69-3
Synonyms:Ethanimidamide, 2-chloro-, hydrochloride (1:1);2-chloroacetimidamide hydrochloride;EINECS 233-675-7;2-Chloracetamidine hydrochloride;2-chloroacetamidine monohydrochloride;2-chloroacetamidine;2-CHLOROETHANIMIDAMIDE HYDROCHLORIDE;CHLOROACETAMIDINE HYDROCHLORIDE;MFCD00053013;BUTTPARK 44 3-88;CHLORACETAMIDINE HYDROCHLORIDE;2-Chlor-acetamidin,Hydrochlorid;2-Chloroethanimidamide hydrochloride (1:1);2-CHLORORACETAMIDINE HYDROCHLORIDE;ChloroacetamidineHCl;EthaniMidaMide,2-chloro-,Monohydrochloride;Ethanimidamide, 2-chloro-, monohydrochloride
Molecular Formula:C2H6Cl2N2
Molecular Weight:128.988
HS Code:2925290090
Physical and Chemical Properties:
Melting point:98-103 °C(lit.)
Boiling point:146.4ºC at 760 mmHg
Density:N/A
Index of Refraction:
PSA:49.87000
Exact Mass:127.990807
LogP:1.76320
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN3261
Packing Group:III
Contact us for information like Ethanimidamide, 2-chloro-, hydrochloride (1:1) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Ethanimidamide, 2-chloro-, monohydrochloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Ethanimidamide, 2-chloro-, hydrochloride (1:1) Use and application,MFCD00053013 technical grade,usp/ep/jp grade.
Related News: Its approval has since been called into question, however, and the head of the FDA is now calling for a federal investigation looking into interactions between agency staff and the biotech company. 2,7-Bis(trimethylstannyl)-benzo[1,2-b:4,5-b]bis(4,4′-dioctyl-4H-silolo[3,2-b]thiophene) manufacturers Grégoire Boutonnet, Chief Operating Officer of NOVA, said: “I am thrilled to be joining the NOVA team at this exciting period of growth as we launch the Jinkō platform towards wider adoption in the clinical trial development space. 3a,4,5,6,7,7a-hexahydro-4,7-methanoindene-5-carboxaldehyde diethyl acetal suppliers The relationship between a CDMO and the company also depends on influencing aspects such as transparent communication, involvement at every step, and support while dealing with challenges. 2-methoxy-4-methylbenzenesulfonamide vendor & factory The company will see an immediate $6 billion bump to its topline thanks to Alexion’s C5 inhibitors, used to treat rare diseases like paroxysmal nocturnal hemoglobinuria. ,Grégoire Boutonnet, Chief Operating Officer of NOVA, said: “I am thrilled to be joining the NOVA team at this exciting period of growth as we launch the Jinkō platform towards wider adoption in the clinical trial development space.
